Altered immune response during cadmium administration in mice

Area of Science:

• Immunotoxicology
• Environmental Health

Background:

• Cadmium (Cd) is a toxic heavy metal with known immunomodulatory effects.
• Understanding the dose- and duration-dependent impact of cadmium on immune function is crucial for risk assessment.

Purpose of the Study:

• To investigate the effects of varying cadmium chloride (CdCl2) doses and exposure durations on the immune system of C57BL/6 mice.
• To assess cadmium's impact on T-cell proliferation and antibody-producing cell responses.

Main Methods:

• Mice were exposed to different concentrations of cadmium (50-300 ppm) via drinking water or injection for short (3-4 weeks) and long (9-11 weeks) terms.
• Assessed T-cell proliferative responses to Concanavalin A (Con A) and Phytohemagglutinin (PHA).
• Quantified IgM antibody-forming cells (PFCs) after immunization with sheep red blood cells (SRBC).

Main Results:

• Short-term oral exposure to 50 or 200 ppm cadmium enhanced T-cell proliferation and IgM antibody responses.
• Long-term exposure to 300 ppm cadmium suppressed the antibody response to SRBC.
• Zinc chloride (ZnCl2) administration prevented cadmium-induced enhancement of PFC response.
• Cadmium exposure initially impaired but later recovered the spleen cells' capacity to suppress antibody responses.

Conclusions:

• Cadmium exposure exhibits dose- and duration-dependent immunomodulatory effects in mice.
• Lower cadmium levels may enhance certain immune responses, while higher or prolonged exposure can lead to suppression.
• Zinc may counteract some of cadmium's adverse immune effects.